As of Nov 19, 2026, 2 of 2 active firms rate MDWD a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
MDWD EPS & revenue forecast
EPS · NEXT QUARTER
$-0.60
Range $-0.70 – $-0.53 · 5 analysts · +163% YoY
Next period, 5 analysts expect Mediwound Ltd to earn $-0.60 a share (range $-0.70 – $-0.53), versus $-0.23 a year earlier. Full-year consensus is $-2.02, growing to $-2.24 the year after.
REVENUE · NEXT QUARTER
$6.7M
Range $4.5M – $8.5M · 5 analysts · +355% YoY
Revenue is expected to reach $6.7M (range $4.5M – $8.5M), +354.7% year-over-year. Full-year consensus is $18.4M, rising to $28.3M next year.
Top analysts covering Mediwound Ltd
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on MDWD.
#1
Chase Knickerbocker
Craig-Hallum · Rank #17
Buy
No targeton MDWD
Overall win rate
61%
+ Follow
#2
Francois Brisebois
Oppenheimer · Rank #282
Buy
$32.00+135.3% to target
Overall win rate
40%
+ Follow
#3
Jeff Jones
Oppenheimer · Rank #320
Buy
$30.00+120.6% to target
Overall win rate
32%
+ Follow
#4
Swayampakula Ramakanth
HC Wainwright & Co. · Rank #321
Buy
$36.00+164.7% to target
Overall win rate
38%
+ Follow
#5
JJ
Josh Jennings
TD Cowen
Buy
$25.00+83.8% to target
Coverage
—
+ Follow
MDWD stock forecast FAQ
What is MDWD's average 12-month price target?+
The 2 active firms with a live target average $33.00 for Mediwound Ltd over the next 12 months, ranging from a $36.00 high to a $30.00 low, as of Nov 19, 2026.
Is MDWD stock a Buy, Sell or Neutral right now?+
The current consensus is Insufficient coverage. Of the 2 active firms as of Nov 19, 2026, 2 rate it Buy or Strong Buy, 0 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for MDWD?+
The Street-high target is $36.00 (HC Wainwright & Co.), and the Street-low is $30.00 (Oppenheimer). The average of all 2 active-firm targets is $33.00.
How many active Wall Street firms cover MDWD?+
2 active firms have a recognized rating on Mediwound Ltd as of Nov 19, 2026, and 2 active firms carry a live 12-month price target.
Who is the most accurate analyst covering MDWD?+
Among analysts who currently cover MDWD, Chase Knickerbocker of Craig-Hallum has the strongest overall Quantellect track record (Rank #17). Their current call is Buy.
What is Mediwound Ltd's projected EPS for next quarter?+
The consensus estimate is $-0.60 per share (range $-0.70 – $-0.53) across 5 analysts. Full-year EPS is projected at $-2.02, rising to $-2.24 the following year.
How much revenue is Mediwound Ltd expected to report next quarter?+
Consensus revenue is $6.7M (range $4.5M – $8.5M). Full-year revenue is projected at $18.4M, growing to $28.3M next year.
Have analysts been upgrading or downgrading MDWD lately?+
As of Nov 19, 2026, 2 of 2 active firms rate MDWD a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their MDWD calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.